1,662 results on '"Galeazzi, M."'
Search Results
102. Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis
- Author
-
Guideri, F, Acampa, M, Rechichi, S, Capecchi, P L, Lazzerini, P E, Galeazzi, M, Auteri, A, and Laghi-Pasini, F
- Published
- 2006
103. Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis
- Author
-
Morozzi, G, Bellisai, F, Fioravanti, A, and Galeazzi, M
- Published
- 2005
104. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed
- Author
-
Frediani, B, Filippou, G, Falsetti, P, Lorenzini, S, Baldi, F, Acciai, C, Siagkri, C, Marotto, D, Galeazzi, M, and Marcolongo, R
- Published
- 2005
105. Two Single-Nucleotide Polymorphisms in the 5′ and 3′ Ends of the Osteopontin Gene Contribute to Susceptibility to Systemic Lupus Erythematosus
- Author
-
DʼAlfonso, S., Barizzone, N., Giordano, M., Chiocchetti, A., Magnani, C., Castelli, L., Indelicato, M., Giacopelli, F., Marchini, M., Scorza, R., Danieli, M. G., Cappelli, M., Migliaresi, S., Bigliardo, B., Sabbadini, M. G., Baldissera, E., Galeazzi, M., Sebastiani, G. D., Minisola, G., Ravazzolo, R., Dianzani, U., and Momigliano-Richiardi, P.
- Published
- 2005
106. Cosmic ray effects in microcalorimeter arrays
- Author
-
Stahle, C.K., Boyce, K.R., Brown, G.V., Cottam, J., Figueroa-Feliciano, E., Galeazzi, M., Kelley, R.L., McCammon, D., Porter, F.S., Szymkowiak, A.E., and Tillotson, W.A.
- Published
- 2004
- Full Text
- View/download PDF
107. Design of the second generation XRS detector
- Author
-
Galeazzi, M, Boyce, K.R, Brown, G.V, Chen, C, Cottam, J, Figueroa-Feliciano, E, Jacobson, M.B, Kelley, R.L, Liu, D, McCammon, D, Porter, F.S, Rocks, L.E, Stahle, C.K, Szymkowiak, A.E, and Vaillancourt, J.E
- Published
- 2004
- Full Text
- View/download PDF
108. The next-generation microcalorimeter array of XRS on Astro-E2
- Author
-
Stahle, C.K., Allen, C.A., Boyce, K.R., Brekosky, R.P., Brown, G.V., Cottam, J., Figueroa-Feliciano, E., Galeazzi, M., Gygax, J.D., Jacobson, M.B., Kelley, R.L., Liu, D., McCammon, D., McClanahan, R.A., Moseley, S.H., Porter, F.S., Rocks, L.E., Szymkowiak, A.E., and Vaillancourt, J.E.
- Published
- 2004
- Full Text
- View/download PDF
109. Fabrication process responsible for fundamentally improving Silicon X-ray microcalorimeter arrays
- Author
-
Brekosky, R.P., Allen, C.A., Galeazzi, M., Gygax, J.D., Isenburg, H., Kelley, R.L., McCammon, D., McClanahan, R.A., Porter, F.S., Stahle, C.K., and Szymkowiak, A.E.
- Published
- 2004
- Full Text
- View/download PDF
110. X-ray survey with microcalorimeters: from GRB in the far universe to diffuse emission in our galaxy
- Author
-
Piro, L., Colasanti, L., Gandolfi, G., Pacciani, L., De Rosa, A., Hampai, D., Costa, E., Feroci, M., Soffitta, P., Gatti, F., Pergolesi, D., Vaccarone, R., Orio, M., Ferrari, A., Trussoni, E., McCammon, D., Sanders, W.T., Porter, F.S., Kelley, R.L., Stahle, C.K., Figueroa, E., Szymkowiak, A., and Galeazzi, M.
- Published
- 2004
- Full Text
- View/download PDF
111. Intrinsic noise sources in superconductors near the transition temperature
- Author
-
Galeazzi, M, Zuo, F, Chen, C, and Ursino, E
- Published
- 2004
- Full Text
- View/download PDF
112. Performance of resistive microcalorimeters and bolometers
- Author
-
Galeazzi, M
- Published
- 2004
- Full Text
- View/download PDF
113. Iridium thin films deposited via pulsed laser deposition for future applications as transition-edge sensors
- Author
-
Galeazzi, M., Chen, C., Cohn, J.L., and Gundersen, J.O.
- Published
- 2004
- Full Text
- View/download PDF
114. Large area bismuth absorbers for X-ray microcalorimeters
- Author
-
Vaillancourt, J.E, Allen, C.A, Brekosky, R, Dosaj, A, Galeazzi, M, Kelley, R, Liu, D, McCammon, D, Porter, F.S, Rocks, L.E, Sanders, W.T, and Stahle, C.K
- Published
- 2004
- Full Text
- View/download PDF
115. Real-World-Daten zur Verwendung von Certolizumab Pegol bei axialer Spondyloarthritis in der klinischen Praxis in Europa: 24-Wochen-Ergebnisse einer prospektiven, nicht-interventionellen Kohortenstudie
- Author
-
Baraliakos, X, Goodson, N, Witte, T, De Clerk, L, Galeazzi, M, Collantes-Estévez, E, Kumke, T, Baraliakos, X, Goodson, N, Witte, T, De Clerk, L, Galeazzi, M, Collantes-Estévez, E, and Kumke, T
- Published
- 2019
116. Rapid and sustained efficacy of golimumab in the treatment of multirefractory uveitis associated with Behçet’s disease
- Author
-
Fabiani, C, Sota, J, Rigante, Donato, Vitale, A, Emmi, G, Vannozzi, L, Franceschini, R, Bacherini, D, Frediani, B, Galeazzi, M, Tosi, Gm, Cantarini, L., Rigante, Donato (ORCID:0000-0001-7032-7779), Fabiani, C, Sota, J, Rigante, Donato, Vitale, A, Emmi, G, Vannozzi, L, Franceschini, R, Bacherini, D, Frediani, B, Galeazzi, M, Tosi, Gm, Cantarini, L., and Rigante, Donato (ORCID:0000-0001-7032-7779)
- Abstract
PURPOSE: To evaluate golimumab (GOL) efficacy in the management of Behçet's disease (BD)-related uveitis. METHODS: We retrospectively collected data from 5 patients (8 eyes) with at least two recent relapses of uveitis, treated with GOL at the standard dose of 50 mg every 4 weeks. RESULTS: A complete control of intraocular inflammation was observed in 7/8 eyes (87.5%) at 12-month follow-up. The number of relapses 12 months before and after GOL initiation was 11 and 1, respectively. At baseline, four eyes had active retinal vasculitis (RV). At 3-month follow-up evaluation RV resolved in all eyes. Mean Best Corrected Visual Acuity was 6.93 ± 4.34 at baseline and 7.32 ± 3.87 at 12-months follow-up. CONCLUSION: We confirm GOL efficacy in reducing intraocular inflammation in BD, both in term of reduction in the number of uveitis relapses and in achieving a prompt resolution of active RV.
- Published
- 2019
117. Bone mineral density in patients with systemic sclerosis
- Author
-
Frediani, B, Baldi, F, Falsetti, P, Acciai, C, Filippou, G, Spreafico, A, Chellini, F, Capperucci, C, Filipponi, P, Galeazzi, M, and Marcolongo, R
- Published
- 2004
118. Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: A prospective study
- Author
-
Sebastiani, G. D., Passiu, G., Galeazzi, M., Porzio, F., and Carcassi, U.
- Published
- 1991
- Full Text
- View/download PDF
119. High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort
- Author
-
Annunziata, P., Morana, P., Giorgio, A., Galeazzi, M., Campanella, V., Loreʼ, F., and Guarino, E.
- Published
- 2003
120. Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment
- Author
-
Lazzerini, P E, Capecchi, P L, Bisogno, S, Galeazzi, M, Marcolongo, R, and Pasini, F Laghi
- Published
- 2003
121. The Line Emission Mapper (LEM) probe mission concept
- Author
-
den Herder, Jan-Willem A., Nikzad, Shouleh, Nakazawa, Kazuhiro, Kraft, R., Bogdán, Á., ZuHone, J., Adams, J. S., Alvarado-Gómez, J. D., Argiroffi, C., Ayromlou, M., Azadi, M., Bandler, S. R., Barbera, M., Bhardwaj, A., Biffi, V., Bodewits, D., Boettcher, E., Branham, B., Burchett, J. N., Burke, D. J., Cann, J., Carter, J. A., Castro, D., Chakraborty, P., Chan, K. W., Chen, S., Churazov, E., Coderre, K., Corcoran, M. F., Cumbee, R. S., DePalo, S. V., Dolag, K., Donahue, M., Doriese, W. B., Drake, J. J., Dunn, W., Eckart, M. E., Eckert, D., Ettori, S., Ezoe, Y., Feldman, C. H., Flaccomio, E., Forman, W. R., Galeazzi, M., Gall, A. C., Garraffo, C., Gonzalez, M., Grosso, N., Hartley, J., Hell, N., Hernquist, L., Hodges-Kluck, E., Houston, J., Hull, S. V., Islam, N., Janas, P. M., Jennings, F. J., Jones, C., Kaaret, P., Kanner, H., Karovska, M., Kashyap, V., Kavanagh, P. J., Kelley, R. L., Khabibullin, I., Kilbourne, C. A., Kim, C.-G., Koutroumpa, D., Kovács, O. E., Kuntz, K. D., Lee, S.-H., Leutenegger, M. A., Linn, T., Lotti, S., Markevitch, M., Martin, K., May, L., McCammon, D., McEntee, S. C., Mei, S., Mernier, F., Miceli, M., Miller, J. B., Mirakhor, M. S., Monsch, K., Nazé, Y., Nelson, D., Nordt, A. A., Ogorzalek, A., Olson, J., Orlando, S., Osborne, E., Oskinova, L. M., Patnaude, D., Pfeifle, R. W., Pinto, C., Plucinsky, P., Ponti, G., Porquet, D., Porter, F. S., Préle, D., Ramm, S., Randall, S. W., Rasia, E., Rau, M. M., Richardson, S., Sakai, K. S., Sarkar, A., Schellenberger, G., Sciortino, S., Schaye, J., Simionescu, A., Smith, S. J., Sobolewska, M., Steiner, J. F., Stern, J., Su, Y., Sun, M., Truong, N., Ursino, E., Valentini, M., Veilleux, S., Vladutescu-Zopp, S., Vogelsberger, M., Wakeham, N. A., Walker, S. A., Wang, Q. D., Wargelin, B., Weaver, K. A., Werk, J. K., Werner, N., Wolk, S. J., Zhang, C., Zhang, W. W., and Zhuravleva, I.
- Published
- 2024
- Full Text
- View/download PDF
122. ANTIPHOSPHOLIPID SYNDROME (APS): PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS.
- Author
-
Cervera, R, Piette, J C, Font, J, Khamashta, M A, Shoenfeld, Y, Camps, M T, Jacobsen, S, Lakos, G, Tincani, A, Kontopoulo-Griva, I, Galeazzi, M, Meroni, P L, Derksen, R HWM, de Groot, F G, Gromnica-Ihle, E, Baleva, M, Bombardieri, S, Houssiau, F, Gris, J C, Quere, I, Hachulla, E, Vasconcelos, C, Roch, B, Fernandez-Nebro, A, Boffa, M, Hughes, G RV C, and Ingelmo, M
- Published
- 2001
123. Increased levels of NGF in sera of systemic lupus erythematosus patients
- Author
-
Bracci-Laudiero, L., primary, Aloe, L., additional, Levi-Montalcini, R., additional, Galeazzi, M., additional, Schilter, D., additional, Scully, J. L., additional, and Otten, U., additional
- Published
- 1997
- Full Text
- View/download PDF
124. Erratum to: One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial
- Author
-
Fioravanti, A., Bacaro, G., Giannitti, C., Tenti, S., Cheleschi, S., Guidelli, G. M., Pascarelli, N. A., and Galeazzi, M.
- Published
- 2015
- Full Text
- View/download PDF
125. Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition disease
- Author
-
Filippou, G, Adinolfi, A, Cimmino, M, Scire, C, Carta, S, Lorenzini, S, Santoro, P, Sconfienza, L, Bertoldi, I, Picerno, V, Di Sabatino, V, Ferrata, P, Galeazzi, M, Frediani, B, Filippou G., Adinolfi A., Cimmino M. A., Scire C. A., Carta S., Lorenzini S., Santoro P., Sconfienza L. M., Bertoldi I., Picerno V., Di Sabatino V., Ferrata P., Galeazzi M., Frediani B., Filippou, G, Adinolfi, A, Cimmino, M, Scire, C, Carta, S, Lorenzini, S, Santoro, P, Sconfienza, L, Bertoldi, I, Picerno, V, Di Sabatino, V, Ferrata, P, Galeazzi, M, Frediani, B, Filippou G., Adinolfi A., Cimmino M. A., Scire C. A., Carta S., Lorenzini S., Santoro P., Sconfienza L. M., Bertoldi I., Picerno V., Di Sabatino V., Ferrata P., Galeazzi M., and Frediani B.
- Abstract
Objective To assess the diagnostic performance of ultrasound (US), x-rays, and microscopic analysis of synovial fluid (SF) for calcium pyrophosphate dihydrate crystal deposition disease (CPPD) using histology as a reference standard Methods We enrolled consecutive patients with osteoarthritis waiting to undergo knee replacement surgery. Each patient underwent US of the knee, focusing on menisci and the hyaline cartilage, the day before surgery. During surgery, SF, menisci and condyles were retrieved and examined microscopically. For the meniscus and cartilage microscopic analysis, 8 samples were collected from each specimen and knee radiographs, performed up to 3 months before surgery, were also assessed. A dichotomous score was given for the presence/absence of CPP for each method. Microscopic findings of the specimens were considered the reference standard. All the procedures followed were in accordance with the ethical standards of the local responsible committee. Results 42 patients (14 males) were enrolled. All patients underwent US, 34 had eligible radiographs and 32 had SF analysis. 25 patients (59.5%) were positive for CPP at US, 15 (44.1%) at X-ray and 14 (43.7%) at SF. Sensitivity and specificity values were 96% and 87% for US, 75% and 93% for radiography and 77% and 100% for SF respectively. There were no statistically significant differences between the diagnostic performance across single tests. Conclusion US proved to be at least as accurate as SF analysis for the diagnosis of CPPD. US, which is feasible and harmless, could be considered the first exam of choice for CPPD diagnosis.
- Published
- 2016
126. Detection of environmental fine structure in the low-energy beta-decay spectrum of187 Re
- Author
-
Gatti, F., Fontanelli, F., Galeazzi, M., Swift, A. M., and Vitale, S.
- Published
- 1999
127. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers
- Author
-
Gentileschi, S., Vitale, A., Rigante, D., Lopalco, G., Emmi, G., Orlando, I., Di Scala, G., Sota, J., Fabiani, C., Frediani, B., Galeazzi, M., Giovanni Lapadula, Iannone, F., and Cantarini, L.
- Subjects
Adult ,Male ,secukinumab ,Antibodies, Monoclonal ,Blood Sedimentation ,Middle Aged ,Antibodies, Monoclonal, Humanized ,Severity of Illness Index ,C-Reactive Protein ,Treatment Outcome ,interleukin (IL)-17 ,Italy ,axial spondyloarthritis (axSpA) ,seronegative arthritis ,Humans ,Female ,Spondylitis, Ankylosing ,Referral and Consultation ,Aged - Abstract
Clinical research is needed to identify patients with axial spondyloarthritis (axSpA) who are more likely to be responsive to interleukin (IL)-17 inhibition.To evaluate short-term efficacy of secukinumab in the management of axSpA.Twenty-one patients (7 males, 14 females) with axSpA were consecutively treated with secukinumab. Laboratory and clinical assessments were based on erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Ankylosing Spondylitis Disease Activity Score (ASDAS)-CRP, and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Data were recorded at baseline and at a 3 month follow-up visit.The study was comprised of 21 patients. Both BASDAI and ASDAS-CRP showed a statistically significant reduction between the baseline and the 3 month visit (P0.0001 and P = 0.0005, respectively). During the laboratory assessment, ESR showed a significant decrease (P = 0.008) while CRP improvement did not reach statistical significance (P = 0.213). No statistical significance was observed between patients treated with secukinumab 150 mg vs. 300 mg in BASDAI (P=0.99), ASDAS-CRP (P = 0.69), ESR (P = 0.54), and CRP (P = 0.56). No significant differences emerged between the BASDAI (P = 0.15), ASDAS-CRP (P = 0.09), and CRP (P = 0.15) rates in biologic-naïve patients and those previously failing tumor necrosis factor-α inhibition. Conversely, ESR decrease was significantly higher in the biologic-naïve subgroup (P = 0.01). No adverse events were reported.Secukinumab has proven remarkable short-term effectiveness, regardless of the biologic treatment line. A dosage of 150 mg proved to be appropriate in the clinical and laboratory management of axSpA.
- Published
- 2018
128. Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement
- Author
-
Marchesoni, A., D Angelo, S., Anzidei, M., Bortolotti, R., Cantini, F., Caramella, D., Carotti, M., Maria Sole Chimenti, Delle Sedie, A., Egan, C. G., Fabbroni, M., Frediani, B., Fusaro, E., Galeazzi, M., Gallazzi, M. B., Gentileschi, S., Gentili, F., Gerli, R., Gilio, M., Iannone, F., La Paglia, E., Lubrano, E., Macarini, L., Olivieri, I., Pellerito, R., Ramonda, R., Salvarani, C., Scarano, E., Scarpa, R., Spaggiari, L., Spanò, A., Zawaideh, J. P., Mazzei, M. A., Marchesoni, Antonio, D'Angelo, Salvatore, Anzidei, Michele, Bortolotti, Roberto, Cantini, Fabrizio, Caramella, Davide, Carotti, Marina, Chimenti, Maria Sole, Delle Sedie, Andrea, Egan, Colin Gerard, Fabbroni, Marta, Frediani, Bruno, Fusaro, Enrico, Galeazzi, Mauro, Gallazzi, Mauro Battista, Gentileschi, Stefano, Gentili, Francesco, Gerli, Roberto, Gilio, Michele, Iannone, Florenzo, La Paglia, Ernesto, Lubrano, Ennio, Macarini, Luca, Olivieri, Ignazio, Pellerito, Raffaele, Ramonda, Roberta, Salvarani, Carlo, Scarano, Enrico, Scarpa, Raffaele, Spaggiari, Lucia, Spanò, Angelo, Zawaideh, Jeries Paolo, and Mazzei, Maria Antonietta
- Subjects
Consensus ,Delphi Technique ,Consensu ,Humans ,Interdisciplinary Communication ,Italy ,Radiologists ,Rheumatologists ,Spondylarthritis ,Settore MED/16 - Reumatologia ,Radiologist ,Rheumatologist ,Human - Abstract
The aim of this study was to develop a Delphi consensus statement between rheumatologists and radiologists for the diagnosis and monitoring of axial spondyloarthritis (axial-SpA).Following an extensive literature search to identify unmet needs and potential goals for a multidisciplinary approach, a scientific board comprising 28 Italian hospital-based rheumatologists (n=19) and radiologists (n=9) identified 8 "starting points", resulting in the development of 23 consensus statements covering issues from current practice guidelines to specific MRI protocols for the assessment of axial-SpA. Each participant anonymously expressed a level of agreement for each statement using a 5-point Likert scale (1="strongly disagree"; 5="strongly agree") via an online Delphi method.Total cumulative agreement (TCA) was defined as the sum of the percentage of response to items 4 ("agree") and 5 ("absolutely agree"). Consensus was defined as ≥80% total cumulative agreement for each statement.After the first round of voting (28 participants), positive consensus was reached for 28/31 (90.3%) statements. Statements without consensus (n=3) were discussed in a face-to-face plenary session prior to the second vote (28 participants). After the second round voting, positive consensus was attained for all 31 statements, with mean final TCA of 95.5% (range 82.1-100%).This Delphi consensus statement provides an aid to rheumatologists and radiologists for the diagnosis and monitoring of axial-SpA.
- Published
- 2018
129. Atmospheric gas dynamics in the Perseus cluster observed with Hitomi*
- Author
-
Aharonia, F., Aharonian, F., Akamatsu, H., Akimoto, F., Allen, S. W., Angelini, L., Audard, M., Awaki, H., Axelsson, M., Bamba, A., Bautz, M. W., Blandford, R., Brenneman, L. W., Brown, G. V., Bulbul, E., Cackett, E. M., Canning, R. E. A., Chernyakova, M., Chiao, M. P., Coppi, P. S., Costantini, E., Plaa, J., Vries, C. P., Den Herder, J. -W, Done, C., Dotani, T., Ebisawa, K., Eckart, M. E., Enoto, T., Ezoe, Y., Fabian, A. C., Ferrigno, C., Foster, A. R., Fujimoto, R., Fukazawa, Y., Furuzawa, A., Galeazzi, M., Gallo, L. C., Gandhi, P., Giustini, M., Goldwurm, A., Gu, L., Guainazzi, M., Haba, Y., Hagino, K., Hamaguchi, K., Harrus, I. M., Hatsukade, I., Hayashi, K., Hayashi, T., Hayashida, K., Hiraga, J. S., Hornschemeier, A., Hoshino, A., Hughes, J. P., Ichinohe, Y., Iizuka, R., Inoue, H., Inoue, S., Inoue, Y., Ishida, M., Ishikawa, K., Ishisaki, Y., Iwai, M., Kaastra, J., Kallman, T., Kamae, T., Kataoka, J., Katsuda, S., Kawai, N., Kelley, R. L., Kilbourne, C. A., Kitaguchi, T., Kitamoto, S., Kitayama, T., Kohmura, T., Kokubun, M., Koyama, K., Koyama, S., Kretschmar, P., Krimm, H. A., Kubota, A., Kunieda, H., Laurent, P., Lee, S. -H, Leutenegger, M. A., Limousin, O., Loewenstein, M., Long, K. S., Lumb, D., Madejski, G., Maeda, Y., Maier, D., Makishima, K., Markevitch, M., Matsumoto, H., Kyoko Matsushita, Mccammon, D., Mcnamara, B. R., Mehdipour, M., Miller, E. D., Miller, J. M., Mineshige, S., Mitsuda, K., Mitsuishi, I., Miyazawa, T., Mizuno, T., Mori, H., Mori, K., Mukai, K., Murakami, H., Mushotzky, R. F., Nakagawa, T., Nakajima, H., Nakamori, T., Nakashima, S., Nakazawa, K., Nobukawa, K. K., Nobukawa, M., Noda, H., Odaka, H., Ohashi, T., Ohno, M., Okajima, T., Ota, N., Ozaki, M., Paerels, F., Paltani, S., Petre, R., Pinto, C., Porter, F. S., Pottschmidt, K., Reynolds, C. S., Safi-Harb, S., Saito, S., Sakai, K., Sasaki, T., Sato, G., Sato, K., Sato, R., Sawada, M., Schartel, N., Serlemtsos, P. J., Seta, H., Shidatsu, M., Simionescu, A., Smith, R. K., Soong, Y., Stawarz, Ł., Sugawara, Y., Sugita, S., Szymkowiak, A., Tajima, H., Takahashi, H., Takahashi, T., Takeda, S., Takei, Y., Amagawa, T. T., Tamura, T., Tanaka, K., Tanaka, T., Tanaka, Y., Tanaka, Y. T., Tashiro, M. S., Tawara, Y., Terada, Y., Erashima, Y. T., Tombesi, F., Tomida, H., Tsuboi, Y., Tsujimoto, M., Tsunemi, H., Tsuru, T. G., Uchida, H., Uchiyama, H., Uchiyama, Y., Ueda, S., Ueda, Y., Uno, S., Urry, C. M., Ursino, E., Wang, Q. H. S., Watanabe, S., Werner, N., Wilkins, D. R., Williams, B. J., Yamada, S., Yamaguchi, H., Yamaoka, K., Yamasaki, N. Y., Yamauchi, M., Yamauchi, S., Yaqoob, T., Yatsu, Y., Yonetoku, D., Zhuravleva, I., Zoghbi, A., AstroParticule et Cosmologie (APC (UMR_7164)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Hitomi, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7), AstroParticule et Cosmologie ( APC - UMR 7164 ), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de Physique Nucléaire et de Physique des Particules du CNRS ( IN2P3 ) -Observatoire de Paris-Université Paris Diderot - Paris 7 ( UPD7 ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ), and Commissariat à l'énergie atomique et aux énergies alternatives ( CEA )
- Subjects
galaxies: clusters: individual ,galaxies: clusters: intracluster medium ,Active galactic nucleus ,[ PHYS.ASTR ] Physics [physics]/Astrophysics [astro-ph] ,individual (NGC 1275) [galaxies] ,Astrophysics::High Energy Astrophysical Phenomena ,FOS: Physical sciences ,galaxies: individual ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics ,clusters: individual (Perseus) [galaxies] ,01 natural sciences ,Intracluster medium ,0103 physical sciences ,Emission spectrum ,Brightest cluster galaxy ,010303 astronomy & astrophysics ,STFC ,Astrophysics::Galaxy Astrophysics ,astro-ph.HE ,High Energy Astrophysical Phenomena (astro-ph.HE) ,Physics ,Settore FIS/05 ,010308 nuclear & particles physics ,Velocity gradient ,RCUK ,Velocity dispersion ,Astronomy and Astrophysics ,Redshift ,ST/J003697/2 ,clusters: intracluster medium [galaxies] ,Space and Planetary Science ,X-rays: galaxies: clusters ,Electron temperature ,galaxies: clusters [X-rays] ,ST/L00075X/1 ,Astrophysics - High Energy Astrophysical Phenomena ,[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph] - Abstract
著者人数: Hitomi Collaboration 197名(所属. 宇宙航空研究開発機構宇宙科学研究所(JAXA)(ISAS): 堂谷, 忠靖; 海老沢, 研; 林, 克洋; 林, 佑; 飯塚, 亮; 井上, 芳幸; 石田, 学; 石川, 久美; 岩井, 将親; 国分, 紀秀; 小山, 志勇; 前田, 良知; 満田, 和久; 中川, 貴雄; 尾崎, 正伸; 佐藤, 悟郎; 佐藤, 理江; Simionescu, Aurora; 菅原, 泰晴; 高橋, 忠幸; 竹井, 洋; 田村, 隆幸; 田中, 靖郎; 冨田, 洋; 辻本, 匡弘; 上田, 周太朗; 渡辺, 伸; 山崎, 典子), Number of authors: Hitomi Collaboration 197 (Affiliation. Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency (JAXA)(ISAS): Dotani, Tadayasu; Ebisawa, Ken; Hayashi, Katsuhiro; Hayashi, Tasuku; Iizuka, Ryo; Inoue, Yoshiyuki; Ishida, Manabu; Ishikawa, Kumi; Iwai, Masachika; Kokubun, Motohide; Koyama, Shu; Maeda, Yoshitomo; Mitsuda, Kazuhisa; Nakagawa, Takao; Ozaki, Masanobu; Sato, Goro; Sato, Rie; Simionescu, Aurora; Sugawara, Yasuharu; Takahashi, Tadayuki; Takei, Yoh; Tamura, Takayuki; Tanaka, Yasuo; Tomida, Hiroshi; Tsujimoto, Masahiro; Ueda, Shutaro; Watanabe, Shin; Yamasaki, Noriko Y.), Accepted: 201710-31, 資料番号: SA1170334000
- Published
- 2018
130. Atomic data and spectral modeling constraints from high-resolution X-ray observations of the Perseus cluster with Hitomi
- Author
-
Hitomi, C, Aharonian, F, Akamatsu, H, Akimoto, F, Allen, Sw, Angelini, L, Audard, M, Awaki, H, Axelsson, M, Bamba, A, Bautz, Mw, Blandford, R, Brenneman, Lw, Brown, Gv, Bulbul, E, Cackett, Em, Chernyakova, M, Chiao, Mp, Coppi, Ps, Costantini, E, de Plaa, J, de Vries, Cp, den Herder, J, Done, C, Dotani, T, Ebisawa, K, Eckart, Me, Enoto, T, Ezoe, Y, Fabian, Ac, Ferrigno, C, Foster, Ar, Fujimoto, R, Fukazawa, Y, Furuzawa, A, Galeazzi, M, Gallo, Lc, Gandhi, P, Giustini, M, Goldwurm, A, Liyi, G, Guainazzi, M, Haba, Y, Hagino, K, Hamaguchi, K, Harrus, Im, Hatsukade, I, Hayashi, K, Hayashi, T, Hayashida, K, Hell, N, Hiraga, Js, Hornschemeier, A, Hoshino, A, Hughes, Jp, Ichinohe, Y, Iizuka, R, Inoue, H, Inoue, Y, Ishida, M, Ishikawa, K, Ishisaki, Y, Iwai, M, Kaastra, J, Kallman, T, Kamae, T, Kataoka, J, Katsuda, S, Kawai, N, Kelley, Rl, Kilbourne, Ca, Kitaguchi, T, Kitamoto, S, Kitayama, T, Kohmura, T, Kokubun, M, Koyama, K, Koyama, S, Kretschmar, P, Krimm, Ha, Kubota, A, Kunieda, H, Laurent, P, Lee, S, Leutenegger, Ma, Limousin, O, Loewenstein, M, Long, Ks, Lumb, D, Madejski, G, Maeda, Y, Maier, D, Makishima, K, Markevitch, M, Matsumoto, H, Matsushita, K, Mccammon, D, Mcnamara, Br, Mehdipour, M, Miller, Ed, Miller, Jm, Mineshige, S, Mitsuda, K, Mitsuishi, I, Miyazawa, T, Mizuno, T, Mori, H, Mori, K, Mukai, K, Murakami, H, Mushotzky, Rf, Nakagawa, T, Nakajima, H, Nakamori, T, Nakashima, S, Nakazawa, K, Nobukawa, Kk, Nobukawa, M, Noda, H, Odaka, H, Ohashi, T, Ohno, M, Okajima, T, Ota, N, Ozaki, M, Paerels, F, Paltani, S, Petre, R, Pinto, C, Porter, Fs, Pottschmidt, K, Reynolds, Cs, Safi-Harb, S, Saito, S, Sakai, K, Sasaki, T, Sato, G, Sato, K, Sato, R, Sawada, M, Schartel, N, Serlemtsos, Pj, Seta, H, Shidatsu, M, Simionescu, A, Smith, Rk, Soong, Y, Stawarz, Ł, Sugawara, Y, Sugita, S, Szymkowiak, A, Tajima, H, Takahashi, H, Takahashi, T, Takeda, S, Takei, Y, Tamagawa, T, Tamura, T, Tanaka, T, Tanaka, Y, Tanaka, Yt, Tashiro, Ms, Tawara, Y, Terada, Y, Terashima, Y, Tombesi, F, Tomida, H, Tsuboi, Y, Tsujimoto, M, Tsunemi, H, Tsuru, Tg, Uchida, H, Uchiyama, H, Uchiyama, Y, Ueda, S, Ueda, Y, Uno, S, Urry, Cm, Ursino, E, Watanabe, S, Werner, N, Wilkins, Dr, Williams, Bj, Yamada, S, Yamaguchi, H, Yamaoka, K, Yamasaki, Ny, Yamauchi, M, Yamauchi, S, Yaqoob, T, Yatsu, Y, Yonetoku, D, Zhuravleva, I, Zoghbi, A, Raassen, Ajj, AstroParticule et Cosmologie (APC (UMR_7164)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Hitomi, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7), Observatoire de Paris, and PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
FOS: Physical sciences ,Astrophysics ,X-rays: general ,01 natural sciences ,Measure (mathematics) ,X-ray ,nickel ,benchmark ,iron ,Settore FIS/05 - Astronomia e Astrofisica ,general [X-rays] ,excited state ,0103 physical sciences ,data analysis [methods] ,Calibration ,Emission spectrum ,Sensitivity (control systems) ,cluster ,dielectric ,010306 general physics ,010303 astronomy & astrophysics ,Collisional excitation ,plasma ,instrumentation: spectrographs ,High Energy Astrophysical Phenomena (astro-ph.HE) ,Physics ,Resolution (electron density) ,temperature ,resolution ,Astronomy and Astrophysics ,Plasma ,calibration ,sensitivity ,methods: data analysis ,recombination ,13. Climate action ,Space and Planetary Science ,spectral ,data management ,Astrophysics - High Energy Astrophysical Phenomena ,[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph] ,statistical ,spectrographs [instrumentation] - Abstract
著者人数: Hitomi Collaboration 194名(所属. 宇宙航空研究開発機構宇宙科学研究所(JAXA)(ISAS): 堂谷, 忠靖; 海老沢, 研; 林, 克洋; 飯塚, 亮; 井上, 芳幸; 石田, 学; 石川, 久美; 岩井, 将親; 国分, 紀秀; 小山, 志勇; 前田, 良知; 満田, 和久; 中川, 貴雄; 尾崎, 正伸; 佐藤, 悟郎; 佐藤, 理江; Simionescu, Aurora; 菅原, 泰晴; 高橋, 忠幸; 竹井, 洋; 田村, 隆幸; 田中, 靖郎; 冨田, 洋; 辻本, 匡弘; 上田, 周太朗; 渡辺, 伸; 山崎, 典子), Number of authors: Hitomi Collaboration 194 (Affiliation. Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency (JAXA)(ISAS): Dotani, Tadayasu; Ebisawa, Ken; Hayashi, Katsuhiro; Iizuka, Ryo; Inoue, Yoshiyuki; Ishida, Manabu; Ishikawa, Kumi; Iwai, Masachika; Kokubun, Motohide; Koyama, Shu; Maeda, Yoshitomo; Mitsuda, Kazuhisa; Nakagawa, Takao; Ozaki, Masanobu; Sato, Goro; Sato, Rie; Simionescu, Aurora; Sugawara, Yasuharu; Takahashi, Tadayuki; Takei, Yoh; Tamura, Takayuki; Tanaka, Yasuo; Tomida, Hiroshi; Tsujimoto, Masahiro; Ueda, Shutaro; Watanabe, Shin; Yamasaki, Noriko Y.), Accepted: 2017-12-13, 資料番号: SA1170337000
- Published
- 2018
131. Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective
- Author
-
Galeazzi, M., Alten, R., Chartier, M., Elbez, Y., ENRICO FUSARO, Bars, M. L. E., Lorenz, H. -M, Mariano, G. P., Muratore, M., Nublein, H. G., and Patanè, G.
- Subjects
Abatacept ,Arthritis, Rheumatoid ,Time Factors ,Treatment Outcome ,Italy ,Antirheumatic Agents ,Remission Induction ,Humans ,Prospective Studies ,Retrospective Studies - Published
- 2018
132. Hitomi observations of the LMC SNR N 132 D: Highly redshifted X-ray emission from iron ejecta
- Author
-
Aharonian, Hitomi, C, Felix, Akamatsu, H, Akimoto, F, Allen, Sw, Angelini, L, Audard, M, Awaki, H, Axelsson, M, Bamba, A, Bautz, Mw, Blandford, R, Brenneman, Lw, Brown, Gv, Bulbul, E, Cackett, Em, Chernyakova, M, Chiao, Mp, Coppi, Ps, Costantini, E, de Plaa, J, de Vries, Cp, den Herder, J, Done, C, Dotani, T, Ebisawa, K, Eckart, Me, Enoto, T, Ezoe, Y, Fabian, Ac, Ferrigno, C, Foster, Ar, Fujimoto, R, Fukazawa, Y, Furuzawa, A, Galeazzi, M, Gallo, Lc, Gandhi, P, Giustini, M, Goldwurm, A, Liyi, G, Guainazzi, M, Haba, Y, Hagino, K, Hamaguchi, K, Harrus, Im, Hatsukade, I, Hayashi, K, Hayashi, T, Hayashida, K, Hiraga, Js, Hornschemeier, A, Hoshino, A, Hughes, Jp, Ichinohe, Y, Iizuka, R, Inoue, H, Inoue, Y, Ishida, M, Ishikawa, K, Ishisaki, Y, Iwai, M, Kaastra, J, Kallman, T, Kamae, T, Kataoka, J, Katsuda, S, Kawai, N, Kelley, Rl, Kilbourne, Ca, Kitaguchi, T, Kitamoto, S, Kitayama, T, Kohmura, T, Kokubun, M, Koyama, K, Koyama, S, Kretschmar, P, Krimm, Ha, Kubota, A, Kunieda, H, Laurent, P, Lee, S, Leutenegger, Ma, Limousin, O, Loewenstein, M, Long, Ks, Lumb, D, Madejski, G, Maeda, Y, Maier, D, Makishima, K, Markevitch, M, Matsumoto, H, Matsushita, K, Mccammon, D, Mcnamara, Br, Mehdipour, M, Miller, Ed, Miller, Jm, Mineshige, S, Mitsuda, K, Mitsuishi, I, Miyazawa, T, Mizuno, T, Mori, H, Mori, K, Mukai, K, Murakami, H, Mushotzky, Rf, Nakagawa, T, Nakajima, H, Nakamori, T, Nakashima, S, Nakazawa, K, Nobukawa, Kk, Nobukawa, M, Noda, H, Odaka, H, Ohashi, T, Ohno, M, Okajima, T, Ota, N, Ozaki, M, Paerels, F, Paltani, S, Petre, R, Pinto, C, Porter, Fs, Pottschmidt, K, Reynolds, Cs, Safi-Harb, S, Saito, S, Sakai, K, Sasaki, T, Sato, G, Sato, K, Sato, R, Sato, T, Sawada, M, Schartel, N, Serlemtsos, Pj, Seta, H, Shidatsu, M, Simionescu, A, Smith, Rk, Soong, Y, Stawarz, Ł, Sugawara, Y, Sugita, S, Szymkowiak, A, Tajima, H, Takahashi, H, Takahashi, T, Takeda, S, Takei, Y, Tamagawa, T, Tamura, T, Tanaka, T, Tanaka, Y, Tanaka, Yt, Tashiro, Ms, Tawara, Y, Terada, Y, Terashima, Y, Tombesi, F, Tomida, H, Tsuboi, Y, Tsujimoto, M, Tsunemi, H, Tsuru, Tg, Uchida, H, Uchiyama, H, Uchiyama, Y, Ueda, S, Ueda, Y, Uno, S, Urry, Cm, Ursino, E, Watanabe, S, Werner, N, Wilkins, Dr, Williams, Bj, Yamada, S, Yamaguchi, H, Yamaoka, K, Yamasaki, Ny, Yamauchi, M, Yamauchi, S, Yaqoob, T, Yatsu, Y, Yonetoku, D, Zhuravleva, I, Zoghbi, A, AstroParticule et Cosmologie (APC (UMR_7164)), Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Hitomi, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), AstroParticule et Cosmologie ( APC - UMR 7164 ), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de Physique Nucléaire et de Physique des Particules du CNRS ( IN2P3 ) -Observatoire de Paris-Université Paris Diderot - Paris 7 ( UPD7 ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ), Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7), and Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
- Subjects
[ PHYS.ASTR ] Physics [physics]/Astrophysics [astro-ph] ,observational [methods] ,FOS: Physical sciences ,Astrophysics ,01 natural sciences ,individual objects (N 132 D) [ISM] ,Settore FIS/05 - Astronomia e Astrofisica ,0103 physical sciences ,Spectral resolution ,010306 general physics ,Large Magellanic Cloud ,Ejecta ,Supernova remnant ,010303 astronomy & astrophysics ,Line (formation) ,ISM: supernova remnants ,instrumentation: spectrographs ,Physics ,High Energy Astrophysical Phenomena (astro-ph.HE) ,supernova remnants [ISM] ,individual (N 132 D) [X-rays] ,Astronomy and Astrophysics ,X-rays: individual (N 132 D) ,Redshift ,Interstellar medium ,Supernova ,ISM: individual object (N 132 D) ,13. Climate action ,Space and Planetary Science ,methods: observational ,Astrophysics - High Energy Astrophysical Phenomena ,[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph] ,spectrographs [instrumentation] - Abstract
著者人数: Hitomi Collaboration 193名(所属. 宇宙航空研究開発機構宇宙科学研究所(JAXA)(ISAS): 堂谷, 忠靖; 海老沢, 研; 林, 克洋; 飯塚, 亮; 井上, 芳幸; 石田, 学; 石川, 久美; 岩井, 将親; 国分, 紀秀; 小山, 志勇; 前田, 良知; 満田, 和久; 中川, 貴雄; 尾崎, 正伸; 佐藤, 悟郎; 佐藤, 理江; Simionescu, Aurora; 菅原, 泰晴; 高橋, 忠幸; 竹井, 洋; 田村, 隆幸; 田中, 靖郎; 冨田, 洋; 辻本, 匡弘; 上田, 周太朗; 渡辺, 伸; 山崎, 典子), Number of authors: Hitomi Collaboration 193 (Affiliation. Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency (JAXA)(ISAS): Dotani, Tadayasu; Ebisawa, Ken; Hayashi, Katsuhiro; Iizuka, Ryo; Inoue, Yoshiyuki; Ishida, Manabu; Ishikawa, Kumi; Iwai, Masachika; Kokubun, Motohide; Koyama, Shu; Maeda, Yoshitomo; Mitsuda, Kazuhisa; Nakagawa, Takao; Ozaki, Masanobu; Sato, Goro; Sato, Rie; Simionescu, Aurora; Sugawara, Yasuharu; Takahashi, Tadayuki; Takei, Yoh; Tamura, Takayuki; Tanaka, Yasuo; Tomida, Hiroshi; Tsujimoto, Masahiro; Ueda, Shutaro; Watanabe, Shin; Yamasaki, Noriko Y.), Masahiro; Ueda, Shutaro; Watanabe, Shin; Yamasaki, Noriko Y.), Accepted: 2017-12-06, 資料番号: SA1170341000
- Published
- 2018
133. Correlation among serum amyloid-A levels, clinical manifestations, treatment, and disease activity in patients with Behçet’s disease
- Author
-
Sota, J, Vitale, A, Rigante, Donato, Orlando, I, Lucherini, Om, Simpatico, A, Lopalco, G, Franceschini, R, Galeazzi, M, Frediani, B, Fabiani, C, Tosi, Gm, and Cantarini, L
- Subjects
Settore MED/16 - REUMATOLOGIA ,Behçet's disease - Published
- 2018
134. The presence of uveitis predicts the response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Behçet's disease
- Author
-
Fabiani, C., Vitale, A., Emmi, G., Lopalco, G., Rigante, Donato, Sota, J., Orlando, I., Frediani, B., Franceschini, R., Galeazzi, M., Iannone, F., Tosi, G. M., and Cantarini, L.
- Subjects
Settore MED/16 - REUMATOLOGIA ,Behçet's disease - Published
- 2018
135. Hitomi X-ray studies of giant radio pulses from the Crab pulsar
- Author
-
Aharonian, Hitomi, C, Felix, Akamatsu, H, Akimoto, F, Allen, Sw, Angelini, L, Audard, M, Awaki, H, Axelsson, M, Bamba, A, Bautz, Mw, Blandford, R, Brenneman, Lw, Brown, Gv, Bulbul, E, Cackett, Em, Chernyakova, M, Chiao, Mp, Coppi, Ps, Costantini, E, de Plaa, J, de Vries, Cp, den Herder, J, Done, C, Dotani, T, Ebisawa, K, Eckart, Me, Enoto, T, Ezoe, Y, Fabian, Ac, Ferrigno, C, Foster, Ar, Fujimoto, R, Fukazawa, Y, Furuzawa, A, Galeazzi, M, Gallo, Lc, Gandhi, P, Giustini, M, Goldwurm, A, Liyi, G, Guainazzi, M, Haba, Y, Hagino, K, Hamaguchi, K, Harrus, Im, Hatsukade, I, Hayashi, K, Hayashi, T, Hayashida, K, Hiraga, Js, Hornschemeier, A, Hoshino, A, Hughes, Jp, Ichinohe, Y, Iizuka, R, Inoue, H, Inoue, Y, Ishida, M, Ishikawa, K, Ishisaki, Y, Iwai, M, Kaastra, J, Kallman, T, Kamae, T, Kataoka, J, Katsuda, S, Kawai, N, Kelley, Rl, Kilbourne, Ca, Kitaguchi, T, Kitamoto, S, Kitayama, T, Kohmura, T, Kokubun, M, Koyama, K, Koyama, S, Kretschmar, P, Krimm, Ha, Kubota, A, Kunieda, H, Laurent, P, Lee, S, Leutenegger, Ma, Limousin, Oo, Loewenstein, M, Long, Ks, Lumb, D, Madejski, G, Maeda, Y, Maier, D, Makishima, K, Markevitch, M, Matsumoto, H, Matsushita, K, Mccammon, D, Mcnamara, Br, Mehdipour, M, Miller, Ed, Miller, Jm, Mineshige, S, Mitsuda, K, Mitsuishi, I, Miyazawa, T, Mizuno, T, Mori, H, Mori, K, Mukai, K, Murakami, H, Mushotzky, Rf, Nakagawa, T, Nakajima, H, Nakamori, T, Nakashima, S, Nakazawa, K, Nobukawa, Kk, Nobukawa, M, Noda, H, Odaka, H, Ohashi, T, Ohno, M, Okajima, T, Oshimizu, K, Ota, N, Ozaki, M, Paerels, F, Paltani, S, Petre, R, Pinto, C, Porter, Fs, Pottschmidt, K, Reynolds, Cs, Safi-Harb, S, Saito, S, Sakai, K, Sasaki, T, Sato, G, Sato, K, Sato, R, Sawada, M, Schartel, N, Serlemtsos, Pj, Seta, H, Shidatsu, M, Simionescu, A, Smith, Rk, Soong, Y, Stawarz, Ł, Sugawara, Y, Sugita, S, Szymkowiak, A, Tajima, H, Takahashi, H, Takahashi, T, Takeda, S, Takei, Y, Tamagawa, T, Tamura, T, Tanaka, T, Tanaka, Y, Tanaka, Yt, Tashiro, Ms, Tawara, Y, Terada, Y, Terashima, Y, Tombesi, F, Tomida, H, Tsuboi, Y, Tsujimoto, M, Tsunemi, H, Tsuru, Tg, Uchida, H, Uchiyama, H, Uchiyama, Y, Ueda, S, Ueda, Y, Uno, S, Urry, Cm, Ursino, E, Watanabe, S, Werner, N, Wilkins, Dr, Williams, Bj, Yamada, S, Yamaguchi, H, Yamaoka, K, Yamasaki, Ny, Yamauchi, M, Yamauchi, S, Yaqoob, T, Yatsu, Y, Yonetoku, D, Zhuravleva, I, Zoghbi, A, Terasawa, T, Sekido, M, Takefuji, K, Kawai, E, Misawa, H, Tsuchiya, F, Yamazaki, R, Kobayashi, E, Kisaka, S, Aoki, T, AstroParticule et Cosmologie (APC (UMR_7164)), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Observatoire de Paris, PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Hitomi, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), AstroParticule et Cosmologie ( APC - UMR 7164 ), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de Physique Nucléaire et de Physique des Particules du CNRS ( IN2P3 ) -Observatoire de Paris-Université Paris Diderot - Paris 7 ( UPD7 ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ), Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Observatoire de Paris, and PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
[ PHYS.ASTR ] Physics [physics]/Astrophysics [astro-ph] ,Astrophysics::High Energy Astrophysical Phenomena ,FOS: Physical sciences ,Magnetosphere ,X-rays: stars ,Astrophysics ,01 natural sciences ,Article ,Radio observatory ,Settore FIS/05 - Astronomia e Astrofisica ,0103 physical sciences ,pulsars: individual (B0531+21) ,010306 general physics ,010303 astronomy & astrophysics ,stars [radio continuum] ,stars [X-rays] ,High Energy Astrophysical Phenomena (astro-ph.HE) ,Physics ,Crab Pulsar ,X-ray ,Astronomy and Astrophysics ,Pulse (physics) ,Space and Planetary Science ,individual (B0531+21) [pulsars] ,Astrophysics - High Energy Astrophysical Phenomena ,[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph] ,radio continuum: stars ,Phase width - Abstract
著者人数: Hitomi Collaboration 203名(所属. 宇宙航空研究開発機構宇宙科学研究所(JAXA)(ISAS): 堂谷, 忠靖; 海老沢, 研; 萩野, 浩一; 林, 克洋; 飯塚, 亮; 井上, 芳幸; 石田, 学; 石川, 久美; 岩井, 将親; 国分, 紀秀; 小山, 志勇; 前田, 良知; 満田, 和久; 中川, 貴雄; 尾崎, 正伸; 佐藤, 悟郎; 佐藤, 理江; Simionescu, Aurora; 菅原, 泰晴; 高橋, 忠幸; 竹井, 洋; 田村, 隆幸; 冨田, 洋; 辻本, 匡弘; 上田, 周太朗; 渡辺, 伸; 山崎, 典子), Number of authors: Hitomi Collaboration 203 (Affiliation. Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency (JAXA)(ISAS): Dotani, Tadayasu; Ebisawa, Ken; Hagino, Kouichi; Hayashi, Katsuhiro; Iizuka, Ryo; Inoue, Yoshiyuki; Ishida, Manabu; Ishikawa, Kumi; Iwai, Masachika; Kokubun, Motohide; Koyama, Shu; Maeda, Yoshitomo; Mitsuda, Kazuhisa; Nakagawa, Takao; Ozaki, Masanobu; Sato, Goro; Sato, Rie; Simionescu, Aurora; Sugawara, Yasuharu; Takahashi, Tadayuki; Takei, Yoh; Tamura, Takayuki; Tomida, Hiroshi; Tsujimoto, Masahiro; Ueda, Shutaro; Watanabe, Shin; Yamasaki, Noriko Y.), Masahiro; Ueda, Shutaro; Watanabe, Shin; Yamasaki, Noriko Y.), Accepted: 2017-07-27, 資料番号: SA1170340000
- Published
- 2018
136. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative
- Author
-
Dick, A. D., Rosenbaum, J. T., Al-Dhibi, H. A., Belfort, R., Brezin, A. P., Chee, S. P., Davis, J. L., Ramanan, A. V., Sonoda, K. -H., Carreno, E., Nascimento, H., Salah, S., Salek, S., Siak, J., Steeples, L., Accorinti, M., Acharya, N., Adan, A., Agrawal, R., Akkoc, N., Al Ghamdi, S., Al Ghamdi, T., Al Saati, A., Alsabaani, N., Al-Shamarani, M., Bachta, A., Barisani-Asenbauer, T., Beare, N., Porto, F. B. O., Blanco, R., Yee, A. C. S., Chandran, V., Chiquet, C., Chng, H. H., Cimbalas, A., Cimino, L., Cordero-Coma, M., Cristobal, C., Cuevas, M., Eurico da Fonseca, J., de Boer, J., de la Torre, A., De Schryver, I., Derzko-Dzulynsky, L., Diaz-Valle, D., Merino, C. E. D., Facsko, A., Figueira, L., Fonollosa, A., Fortin, E., Gale, R., Galeazzi, M., Garcia, S., Garcia Ruiz de Morales, J. M., Gaspersic, N., Goldstein, D., Guedes, M., Guex-Crosier, Y., Gul, A., Hamam, R., Haroon, M., Hasegawa, K., Heiligenhaus, A., Hooper, C., Hwang, Y. -S., Hwang, D. -K., Juanola, X., Kaburaki, T., Kadayifcilar, S., Kempen, J., Kezuka, T., Kherani, A., Kirsimae, M., Kotaniemi, K., Kraut, A., Kubicka-Trzaska, A., Kuffova, L., Lightman, S., Lim, L., Lim, W. K., Mccluskey, P., Mcguire, M., Mirabelli, P., Miserocchi, E., Misiuk-Hojlo, M., Muccioli, C., Munoz, S., Murphy, C., Murray, P., Nagy, Z., Namba, K., Neri, P., Nguyen, Q., O'Gradaigh, D., Omair, M., Otsa, K., Ozyazgan, Y., Pablo, F., Paroli, M. P., Pleyer, U., Poor, G., Proenca, R., Rabinovitch, T., Read, R., Rebrov, M., Recillas-Gispert, C., Rothova, A., Schwartzman, S., Seve, P., Sharma, S., Sims, J., Sohar, N., Suhler, E., Szanto, S., Szepessy, Z., Tappeiner, C., Thorne, J., Tugal Tutkun, I., Turno-Krecicka, A., Van Calster, J., van der Horst-Bruinsma, I., Vidovic Valentincic, N., Vitale, A., Voorduin Ramos, S., Vukojevic, N., Wakefield, D., Willermain, F., Yalcindag, N., Yamamoto, J. H., Yeh, S., Zemaitiene, R., and Ziouzina, O.
- Published
- 2018
137. P1005Origin, distribution and timing of the slow pathway potentials recorded inside the Kock's triangle in Avnrt patients through High-density Mapping
- Author
-
Segreti, L, primary, Lavalle, C, additional, Galeazzi, M, additional, Zingarini, G, additional, Bongiorni, M G, additional, Del Giorno, G, additional, Narducci, M L, additional, Russo, M, additional, Piro, A, additional, Pelargonio, G, additional, Carbone, A, additional, Piccolo, F, additional, Malacrida, M, additional, Pandozi, C, additional, and Colivicchi, F, additional
- Published
- 2019
- Full Text
- View/download PDF
138. HLA-B27 positive ankylosing spondylitis and polyarteritis nodosa: a case report
- Author
-
Galeazzi, M., Fioravanti, A., Minari, C., Selvi, E., Veronesi, M., and Marcolongo, R.
- Published
- 1996
- Full Text
- View/download PDF
139. Intravenous Immunoglobulin Therapy: Modification of the Immunofluorescence Pattern in the Skin of Six Patients with Systemic Lupus Erythematosus
- Author
-
Puddu, P., De Pita, O., Ruffelli, M., Bellucci, A. M., Girardelli, C. R., Galeazzi, M., and Marcolongo, R.
- Published
- 1996
140. Clinical and histological aspects of intravenous immunoglobulin treatment of systemic lupus erythematosus
- Author
-
Bellisai, F., Galeazzi, M., Morozzi, G., and Marcolongo, R.
- Published
- 1995
141. Endoscopic retrograde cholangiopancreatography in the elderly: Results of a retrospective study and a geriatricians' point of view
- Author
-
Galeazzi, M, Mazzola, P, Valcarcel, B, Bellelli, G, Dinelli, M, Pasinetti, G, Annoni, G, Galeazzi, Marianna, Mazzola, Paolo, Valcarcel, Breanna, Bellelli, Giuseppe, Dinelli, Marco, Pasinetti, Giulio Maria, Annoni, Giorgio, Galeazzi, M, Mazzola, P, Valcarcel, B, Bellelli, G, Dinelli, M, Pasinetti, G, Annoni, G, Galeazzi, Marianna, Mazzola, Paolo, Valcarcel, Breanna, Bellelli, Giuseppe, Dinelli, Marco, Pasinetti, Giulio Maria, and Annoni, Giorgio
- Abstract
Background: The incidence of biliary tract pathology is growing with an age-related trend, and progresses as the population ages. Endoscopic Retrograde Cholangiopancreatography (ERCP) represents the gold standard for treatment in these cases, but evidence about its safety in the elderly is still debated. Methods: We retrospectively analyzed the clinical records of all patients aged ≥65 undergoing ERCP between July 2013 and July 2015. Of 387 ERCP cases, 363 (~ 94%) were completed entirely. The mean age of the study population (n = 363) was 79.9 years old (range 70-95), with 190 subjects aged 70-79 and 173 older than 80. We recorded demographics, Charlson Comorbidity index (CCI), American Society of Anesthesiologists (ASA) physical status classification score, indication for the use of the ERCP procedure, and clinical outcomes. Then, we tested all variables to identify the potential risk factors for complications associated with the procedure. Results: The older group (those ≥80 years old) showed significantly more patients with ASA Classes III-IV than the younger one (those ≤79 years old). Interestingly, the CCI was higher in the younger group (p = 0.009). The overall complication rate was 17.3% without inter-group differences. Older age, sex, CCI and intra-ERCP procedures were not related to a higher risk of complications, and the multivariate regression did not identify any of the considered variables to be an independent risk factor for complications. Conclusion: ERCP appears as safe in the patients aged 80 years and older, as it is in those aged 70-79 years old in our study, however, a selection bias may affect these findings. A study including a comprehensive geriatric assessment will contribute to shedding light on this issue.
- Published
- 2018
142. PROMPT CLINICAL RESPONSE TO SECUKINUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: REAL-LIFE OBSERVATIONAL DATA FROM THREE ITALIAN REFERRAL CENTERS
- Author
-
Gentileschi, S, Vitale, A, Rigante, Donato, Lopalco, G, Emmi, G, Orlando, I, di Scala, G, Sota, J, Fabiani, C, Frediani, B, Galeazzi, M, Lapadula, G, Iannone, F, Cantarini, L, Rigante, D (ORCID:0000-0001-7032-7779), Gentileschi, S, Vitale, A, Rigante, Donato, Lopalco, G, Emmi, G, Orlando, I, di Scala, G, Sota, J, Fabiani, C, Frediani, B, Galeazzi, M, Lapadula, G, Iannone, F, Cantarini, L, and Rigante, D (ORCID:0000-0001-7032-7779)
- Abstract
The use of sekunimab in patients with spondyloarthritides is herein discussed
- Published
- 2018
143. The presence of uveitis predicts the response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Behçet's disease
- Author
-
Fabiani, C, Vitale, A, Emmi, G, Lopalco, G, Rigante, Donato, Sota, J, Orlando, I, Frediani, B, Franceschini, R, Galeazzi, M, Iannone, F, Tosi, Gm, Cantarini, L, Rigante, D (ORCID:0000-0001-7032-7779), Fabiani, C, Vitale, A, Emmi, G, Lopalco, G, Rigante, Donato, Sota, J, Orlando, I, Frediani, B, Franceschini, R, Galeazzi, M, Iannone, F, Tosi, Gm, Cantarini, L, and Rigante, D (ORCID:0000-0001-7032-7779)
- Abstract
The paper discusses about the presence of uveitis in patients with Behçet's disease, predicting the response to the interleukin-1 inhibitors anakinra and canakinumab.
- Published
- 2018
144. The impact of psychomotor subtypes and duration of delirium on 6-month mortality in hip-fractured elderly patients
- Author
-
Bellelli, G, Carnevali, L, Corsi, M, Morandi, A, Zambon, A, Mazzola, P, Galeazzi, M, Bonfanti, A, Massariello, F, Szabo, H, Oliveri, G, Haas, J, D'Oro, L, Annoni, G, Bellelli, Giuseppe, Carnevali, Lucio, Corsi, Maurizio, Morandi, Alessandro, Zambon, Antonella, Mazzola, Paolo, Galeazzi, Marianna, BONFANTI, ALESSANDRA MARIA, MASSARIELLO, FRANCESCA, Szabo, Hajnalka, OLIVERI, GIULIA, Haas, Justin, d'Oro, Luca Cavalieri, Annoni, Giorgio, Bellelli, G, Carnevali, L, Corsi, M, Morandi, A, Zambon, A, Mazzola, P, Galeazzi, M, Bonfanti, A, Massariello, F, Szabo, H, Oliveri, G, Haas, J, D'Oro, L, Annoni, G, Bellelli, Giuseppe, Carnevali, Lucio, Corsi, Maurizio, Morandi, Alessandro, Zambon, Antonella, Mazzola, Paolo, Galeazzi, Marianna, BONFANTI, ALESSANDRA MARIA, MASSARIELLO, FRANCESCA, Szabo, Hajnalka, OLIVERI, GIULIA, Haas, Justin, d'Oro, Luca Cavalieri, and Annoni, Giorgio
- Abstract
OBJECTIVE: Studies exploring the incidence and impact of the psychomotor subtypes of postoperative delirium (POD) on the survival of hip fracture patients are few, and results are inconsistent. We sought to assess the incidence of POD subtypes and their impact, in addition to delirium duration, on 6-month mortality in older patients after hip-fracture surgery. METHODS: This is a prospective study involving 571 individuals admitted to an Orthogeriatric Unit within a 5-year period with a diagnosis of hip fracture. Survival status was assessed 6 months after posthip fracture surgery. Postoperative delirium was diagnosed using the Diagnostic and Statistical Manual of Mental Disorders. Postoperative delirium subtypes were classified according to Lipowski's criteria. Cox regressions were used to evaluate the associations between POD subtypes, POD duration, and 6-month mortality, adjusting for covariates. RESULTS: The incidence of psychomotor POD subtypes was hypoactive 57 (10.0%), hyperactive 84 (14.7%), and mixed 79 (13.8%). Six-month mortality rates were 8.3%, 10.7%, 36.8%, and 29.1% in the no-delirium, hyperactive, hypoactive, and mixed-delirium subgroups, respectively. In adjusted models, the hypoactive subgroup (Hazard Ratio, HR = 3.14, 95% Confidence Intervals, CI, 1.63-6.04) and mixed subgroup (HR = 2.89, 95% CI, 1.49-5.62) showed high mortality rates and a significantly increased risk of mortality associated with POD duration as well. CONCLUSIONS: Hyperactive delirium was the most common POD psychomotor subtype, but hypoactive and mixed POD were associated with 6-month mortality risk. Moreover, the risk of death 6 months after surgery increased for both subgroups (hypoactive and mixed) with increasing duration of POD
- Published
- 2018
145. Epidemiological profile of non-infectious uveitis from the rheumatologist’s perspective: a survey from two tertiary referral centres in Italy
- Author
-
Lopalco, G, Venerito, V, Sota, J, Rigante, Donato, Guerriero, S, Orlando, I, Franceschini, R, Favale, R, Lapadula, G, Castelli, B, Frediani, B, Galeazzi, M, La Torre, F, Iannone, F, Tosi, Gm, Fabiani, C, Cantarini, L, Rigante D (ORCID:0000-0001-7032-7779), Lopalco, G, Venerito, V, Sota, J, Rigante, Donato, Guerriero, S, Orlando, I, Franceschini, R, Favale, R, Lapadula, G, Castelli, B, Frediani, B, Galeazzi, M, La Torre, F, Iannone, F, Tosi, Gm, Fabiani, C, Cantarini, L, and Rigante D (ORCID:0000-0001-7032-7779)
- Abstract
OBJECTIVES: To describe the epidemiology of non-infectious uveitis (NIU) in two tertiary referral rheumatology units in Central and Southern Italy. METHODS: Two hundred and seventy-eight consecutive NIU patients (417 eyes) evaluated between January 2016 and January 2017 were enrolled. Collected data were analysed in accordance with the primary anatomic site of inflammation, clinical course, and laterality. RESULTS: The mean age at NIU onset was 36.92±18.30 years with a female-to-male ratio of 1.34:1. Anterior uveitis (AU) was identified in 151 (54.32%), posterior uveitis (PU) in 67 (24.10%), intermediate uveitis (IU) in 5.40% and panuveitis (PanU) in 16.19% patients. Bilateral involvement was identified in 50% of our cohort. Uveitis was acute in 33.81% of patients, while 24.46% and 41.73% had a chronic and recurrent course, respectively. Gender and laterality did not influence the anatomical pattern, while disease course was significantly more acute or chronic in AU (p<0.05) and chronic in IU (p<0.05). An associated systemic disease was identified in 116 patients (41.73%). Twenty-seven patients (9.7%) had a specific isolated eye disease, 135 patients (48.56%) had idiopathic NIU. Uveitis associated with a systemic disease was significantly bilateral (p=0.01) and acute or chronic (p<0.0001), while the isolated form showed an association with chronic course (p<0.0001) and unilaterality (p=0.01). CONCLUSIONS: The most common anatomic pattern of NIU has been AU, followed by PU, PanU and IU. A systemic disease (mainly Behçet's disease, ankylosing spondylitis and juvenile idiopathic arthritis) has been recognised in a fair proportion of the entire cohort. The rheumatologist should remain a central professional figure in the multidisciplinary team dealing with intraocular inflammation on a daily basis.
- Published
- 2018
146. The presence of uveitis is associated with a sustained response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Behçet’s disease
- Author
-
Fabiani, C, Vitale, A, Rigante, Donato, Sota, J, Lopalco, G, Franceschini, R, Frediani, B, Galeazzi, M, Iannone, F, Tosi, Gm, Cantarini, L, Rigante D (ORCID:0000-0001-7032-7779), Fabiani, C, Vitale, A, Rigante, Donato, Sota, J, Lopalco, G, Franceschini, R, Frediani, B, Galeazzi, M, Iannone, F, Tosi, Gm, Cantarini, L, and Rigante D (ORCID:0000-0001-7032-7779)
- Abstract
Purpose: To identify factors associated with sustained response to interleukin (IL)-1 inhibition among demographic, clinical and therapeutic data in patients with Behçet disease (BD). Methods: BD patients treated with anakinra or canakinumab were enrolled. Patients were divided into two groups according to the clinical response: group 1 included subjects showing a treatment duration of at least 52 weeks and no secondary inefficacy during the first follow-up year; the remaining patients were included in the group 2. Demographic, clinical and therapeutic data were analyzed to identify significant differences between groups. Results: Eighteen patients were included in group 1 and 18 patients in group 2. A better response to IL-1 inhibitors was significantly more common among patients with BD-related uveitis (p = 0.006) and patients with a longer disease duration (p = 0.03). Conclusion: IL-1 blockade is effective in BD, especially in the subset of patients presenting eye involvement and in those with long-lasting disease.
- Published
- 2018
147. Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study
- Author
-
Fabiani, C, Sota, J, Vitale, A, Rigante, Donato, Emmi, G, Vannozzi, L, Bacherini, D, Lopalco, G, Guerriero, S, Gentileschi, Stefano, Capozzoli, M, Franceschini, R, Frediani, B, Galeazzi, M, Iannone, F, Tosi, Gm, Cantarini, L., Rigante, Donato (ORCID:0000-0001-7032-7779), Gentileschi, S (ORCID:0000-0001-9682-4706), Fabiani, C, Sota, J, Vitale, A, Rigante, Donato, Emmi, G, Vannozzi, L, Bacherini, D, Lopalco, G, Guerriero, S, Gentileschi, Stefano, Capozzoli, M, Franceschini, R, Frediani, B, Galeazzi, M, Iannone, F, Tosi, Gm, Cantarini, L., Rigante, Donato (ORCID:0000-0001-7032-7779), and Gentileschi, S (ORCID:0000-0001-9682-4706)
- Abstract
BACKGROUND/AIMS: Adalimumab (ADA) has been shown to be an effective treatment for Behçet's disease (BD)-related uveitis. We aimed at evaluating the cumulative retention rate of ADA during a 48-month follow-up period in patients with BD-related uveitis, the impact of a concomitant use of disease modifying anti-rheumatic drugs (DMARDs) on ADA retention rate, and differences according to the various lines of biologic therapy (ie, first- vs second-line or more). Predictive factors of response to ADA were also investigated. METHODS: We enrolled patients diagnosed with BD-related uveitis and treated with ADA between January 2009 and December 2016. Cumulative survival rates were studied using the Kaplan-Meier plot, while the log-rank (Mantel-Cox) test was used to compare survival curves. Statistical analysis was performed to identify differences according to the response to ADA. RESULTS: 54 consecutive patients (82 eyes) were eligible for analysis. The drug retention rate at 12- and 48-month follow-up was 76.9% and 63.5%, respectively. No statistically significant differences were identified according to the use of concomitant DMARDs (p=0.27) and to the different lines of ADA treatment (p=0.37). No significant differences were found between patients continuing and discontinuing ADA in terms of age (p=0.24), age at BD onset (p=0.81), age at uveitis onset (p=0.56), overall BD duration (p=0.055), uveitis duration (p=0.46), human leucocyte antigen-B51 positivity (p=0.51), and gender (p=0.47). CONCLUSIONS: ADA retention rate in BD-related uveitis is excellent and is not affected by the concomitant use of DMARDs or by the different lines of biological therapy. Negative prognostic factors for BD uveitis do not impact ADA efficacy.
- Published
- 2018
148. Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis
- Author
-
Afeltra, A., Galeazzi, M., Ferri, G.M., Amoroso, A., De Pita, O., Porzio, F., and Bonomo, L.
- Subjects
Synovial membranes -- Immunology ,Rheumatoid arthritis -- Physiological aspects ,Synovitis -- Physiological aspects ,T cells -- Physiological aspects ,Health - Abstract
Increased expression of the CD69 antigen may occur on the surface of synovial fluid T cells in patients with rheumatoid arthritis (RA) and other types of chronic synovitis. Chronic synovitis is inflammation of the synovial membrane that lines the joint cavity. Synovial fluid is secreted by the synovial membrane to lubricate the joint. A study examined expression of the CD69 antigen on the surface of synovial fluid and peripheral blood T cells from 12 patients with RA and five patients with other types of chronic synovitis. Expression of the CD69 antigen was also examined in peripheral blood T cells from 15 patients with systemic lupus erythematosus and immune vasculitis. Increased expression of the CD69 antigen was found on the synovial fluid T cells from patients with RA or other types of chronic synovitis. Expression of the CD69 antigen was within a normal range on the peripheral blood T cells from all three patient groups.
- Published
- 1993
149. Detection of environmental fine structure in the low-energy beta-decay spectrum of (super187)Re
- Author
-
Gatti, F., Fontanelli, F., Galeazzi, M., Swift, A.M., and Vitale, S.
- Subjects
Neutrinos -- Research ,Beta decay -- Research ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Neutrino masses can be measured in principle from small distortions in electron spectra, emitted during low-energy beta-decay processes. A cryogenic microcalorimeter was used to to detect beta environmental fine structure in the beta-decay spectrum of (super187)Re. The results agree well with recent theoretical predictions and may help to further studies of molecular structures in a similar way to extended X-ray absorption fine structure.
- Published
- 1999
150. Decrease in Corticosteroid Use in Patients with Rheumatoid Arthritis Who Initiated Intravenous Abatacept Treatment: Results From the 2-Year ACTION Study
- Author
-
Alten, RHE, Mariette, X, Lorenz, HM, Nüßlein, H, Galeazzi, M, Navarro, F, Le Bars, M, Chartier, M, Heitzmann, J, and Rauch, C
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Background: ACTION (AbataCepTIn rOutiNe clinical practice; NCT02109666) is a prospective, real-world study of patients with RA. Important concomitant treatment options for patients with RA include low-dose corticosteroids; however, corticosteroid dose should be tapered as soon as clinically feasible[for full text, please go to the a.m. URL], 45. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 31. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 27. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.